Company Valuation: Changchun BCHT Biotechnology Co.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 28,321 28,531 22,628 9,651 9,651 -
Change - 0.74% -20.69% -57.35% 0% -
Enterprise Value (EV) 28,321 28,531 22,628 9,651 9,651 9,651
Change - 0.74% -20.69% -57.35% 0% 0%
P/E ratio 111x 157x 45.3x 14x 12.8x 9.89x
PBR 8.29x 8.02x 5.63x 2.14x 1.84x 1.58x
PEG -2.4x -5.4x 0x 0.4x 1.4x 0.3x
Capitalization / Revenue 23.6x 26.6x 12.4x 4.9x 3.89x 3.26x
EV / Revenue 0x 0x 0x 4.9x 3.89x 3.26x
EV / EBITDA 0x 0x 0x 13.2x 9.91x 7.84x
EV / EBIT 0x 0x 0x 16.3x 11.4x 8.82x
EV / FCF - - - - - -
FCF Yield - - - - - -
Dividend per Share 2 - 0.15 0.15 0.1633 0.1967 0.24
Rate of return - 0.22% 0.27% 0.7% 0.84% 1.03%
EPS 2 0.62 0.44 1.21 1.67 1.822 2.36
Distribution rate - 34.1% 12.4% 9.78% 10.8% 10.2%
Net sales 1 1,202 1,071 1,825 1,971 2,480 2,958
EBITDA 1 331.2 263.5 651.3 729 973.4 1,230
EBIT 1 261.9 187 559.3 592.5 850.2 1,095
Net income 1 243.6 181.6 501 527 753.4 975.1
Net Debt - - - - - -
Reference price 2 68.60 69.11 54.81 23.33 23.33 23.33
Nbr of stocks (in thousands) 412,841 412,841 412,841 413,658 413,658 -
Announcement Date 2/18/22 2/24/23 2/23/24 - - -
1CNY in Million2CNY
Estimates

P/E ratio, Detailed evolution

Add to a list
P/E ratio (Y) EV / Sales (Y) EV / EBITDA (Y) Yield (Y) Capi.($)
13.97x - - 0.7% 1.32B
20.98x3.21x11.2x1.67% 63.01B
16.24x1.61x6.96x2.73% 7.33B
16.89x8.54x13.9x - 7.26B
83.27x4.9x62.28x0.31% 7.05B
151.02x18.5x100.2x-.--% 6.89B
45.83x8.41x24.54x0.48% 3.32B
13.52x - - 0.85% 2.16B
36.57x - - - 2.12B
Average 44.25x 7.53x 36.51x percentage-no-prefix 11.16B
Weighted average by Cap. 34.53x 4.91x 21.81x percentage-no-prefix
See all sector valuations

Year-on-year evolution of the PER

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Equities
  3. 688276 Stock
  4. Valuation Changchun BCHT Biotechnology Co.